Literature DB >> 1826059

Age-related changes in human D1 dopamine receptors measured by positron emission tomography.

T Suhara1, H Fukuda, O Inoue, T Itoh, K Suzuki, T Yamasaki, Y Tateno.   

Abstract

The effects of age on the binding parameters of 11C-SCH23390, the highly selective ligand for central D1 dopamine receptors, at specific binding sites in the brain were studied. Seventeen healthy male volunteers (20-72 years old) participated. Regional radioactivity in the brain was followed for 40 min by positron emission tomography (PET). A high accumulation of radioactivity was observed in the striatum and there was a conspicuous accumulation in the neocortex. A two-compartment model was used to obtain quantitative estimates of rate constants of association (K3) and dissociation (k4). The binding potential (k3/k4) of the dopamine D1 receptors in the striatum and frontal cortex decreased by 35% and 39%, respectively, with age. The value of k3 decreased by 58% in the striatum and 83% in the frontal cortex, whereas the value of k4 decreased by 35% in the striatum and 72% in the frontal cortex with age.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826059     DOI: 10.1007/bf02244071

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

1.  Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum.

Authors:  O Giorgi; G De Montis; M L Porceddu; S Mele; G Calderini; G Toffano; G Biggio
Journal:  Brain Res       Date:  1987-10       Impact factor: 3.252

2.  Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.

Authors:  M Savasta; A Dubois; B Scatton
Journal:  Brain Res       Date:  1986-06-11       Impact factor: 3.252

3.  The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.

Authors:  S Bischoff; M Heinrich; J M Sonntag; J Krauss
Journal:  Eur J Pharmacol       Date:  1986-10-07       Impact factor: 4.432

4.  Dopamine receptor subtypes: in vivo biochemical evidence for functional interaction.

Authors:  C F Saller; A I Salama
Journal:  Eur J Pharmacol       Date:  1985-02-26       Impact factor: 4.432

5.  Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain.

Authors:  D F Wong; H N Wagner; R F Dannals; J M Links; J J Frost; H T Ravert; A A Wilson; A E Rosenbaum; A Gjedde; K H Douglass
Journal:  Science       Date:  1984-12-21       Impact factor: 47.728

6.  Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography.

Authors:  J J Frost; K H Douglass; H S Mayberg; R F Dannals; J M Links; A A Wilson; H T Ravert; W C Crozier; H N Wagner
Journal:  J Cereb Blood Flow Metab       Date:  1989-06       Impact factor: 6.200

7.  Regional cerebral blood flow and oxygen consumption in human aging.

Authors:  P Pantano; J C Baron; P Lebrun-Grandié; N Duquesnoy; M G Bousser; D Comar
Journal:  Stroke       Date:  1984 Jul-Aug       Impact factor: 7.914

8.  Age-correlated loss of dopaminergic binding sites in human basal ganglia.

Authors:  J A Severson; J Marcusson; B Winblad; C E Finch
Journal:  J Neurochem       Date:  1982-12       Impact factor: 5.372

9.  Reduced dopaminergic binding during aging in the rodent striatum.

Authors:  J A Severson; C E Finch
Journal:  Brain Res       Date:  1980-06-16       Impact factor: 3.252

10.  Age-related differential recovery rates of rat striatal D-1 dopamine receptors following irreversible inactivation.

Authors:  G Battaglia; A B Norman; I Creese
Journal:  Eur J Pharmacol       Date:  1988-01-19       Impact factor: 4.432

View more
  54 in total

Review 1.  Pharmacological implications for neuroreceptor imaging.

Authors:  N P Verhoeff
Journal:  Eur J Nucl Med       Date:  1991

Review 2.  Neurobehavioral evidence for changes in dopamine system activity during adolescence.

Authors:  Dustin Wahlstrom; Tonya White; Monica Luciana
Journal:  Neurosci Biobehav Rev       Date:  2009-12-21       Impact factor: 8.989

3.  Dysregulation of Striatal Dopamine Receptor Binding in Suicide.

Authors:  Megan L Fitzgerald; Suham A Kassir; Mark D Underwood; Mihran J Bakalian; J John Mann; Victoria Arango
Journal:  Neuropsychopharmacology       Date:  2016-07-12       Impact factor: 7.853

4.  Prefronto-cortical dopamine D1 receptor sensitivity can critically influence working memory maintenance during delayed response tasks.

Authors:  Melissa Reneaux; Rahul Gupta
Journal:  PLoS One       Date:  2018-05-29       Impact factor: 3.240

5.  Males, but not females, lose tyrosine hydroxylase fibers in the medial prefrontal cortex and are impaired on a delayed alternation task during aging.

Authors:  Nioka C Chisholm; Taehyeon Kim; Janice M Juraska
Journal:  Behav Brain Res       Date:  2013-01-15       Impact factor: 3.332

6.  Relative lack of cognitive effects of methylphenidate in elderly male volunteers.

Authors:  Danielle C Turner; Trevor W Robbins; Luke Clark; Adam R Aron; Jonathan Dowson; Barbara J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2003-05-07       Impact factor: 4.530

7.  Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease.

Authors:  G Sedvall; P Karlsson; A Lundin; M Anvret; T Suhara; C Halldin; L Farde
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

Review 8.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Authors:  Patricia S Goldman-Rakic; Stacy A Castner; Torgny H Svensson; Larry J Siever; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

9.  Cognitive skill learning in healthy older adults after 2 months of double-blind treatment with piribedil.

Authors:  Charles S Peretti; Fabien Gierski; Sophie Harrois
Journal:  Psychopharmacology (Berl)       Date:  2004-05-12       Impact factor: 4.530

10.  Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112.

Authors:  Dara M Cannon; Jacqueline M Klaver; Summer A Peck; Denise Rallis-Voak; Kristine Erickson; Wayne C Drevets
Journal:  Neuropsychopharmacology       Date:  2008-10-22       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.